BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 27
• 29
• 30
• 31

• Drug Development

  Progenics Pharmaceuticals, Inc. to Advance Oral Methylnaltrexone into Late Stage Clinical Development

  March 12, 2010

   · 

  9 min read
• FDA

  FDA Approves Watson Pharmaceuticals, Inc.'s TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer

  March 12, 2010

   · 

  7 min read
• Genetown

  NxStage Medical, Inc. Secures $15 Million Revolving Line of Credit

  March 12, 2010

   · 

  2 min read
• Drug Development

  XOMA (US) LLC 052 Phase 2 Trial Initiated in Type 1 Diabetes Patients

  March 12, 2010

   · 

  1 min read
• BioMidwest

  Medicis to Present at Roth OC Growth Stock Conference

  March 12, 2010

   · 

  1 min read
• Bio NC

  Chelsea Therapeutics, Inc. to Present at the ROTH 22nd Annual OC Growth Stock Conference on Wednesday, March 17, 2010

  March 12, 2010

   · 

  1 min read
• Business

  Achillion Pharmaceuticals, Inc. Reports 2009 Fourth Quarter and Year-End Financial Results

  March 12, 2010

   · 

  1 min read
• Biotech Bay

  Align Technology, Inc. Executive to Present at ROTH 22nd Annual OC Growth Conference

  March 12, 2010

   · 

  1 min read
• Policy

  IntelliPharmaCeutics Announces Settlement for its Generic Version of Focalin XR(R)

  March 12, 2010

   · 

  1 min read
• Business

  XOMA (US) LLC Reports 2009 and Fourth Quarter Financial Results

  March 12, 2010

   · 

  1 min read